BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12667558)

  • 1. Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis.
    Langdahl BL; Carstens M; Stenkjaer L; Eriksen EF
    Bone; 2003 Mar; 32(3):297-310. PubMed ID: 12667558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fractures.
    Langdahl BL; Gravholt CH; Brixen K; Eriksen EF
    Eur J Clin Invest; 2000 Jul; 30(7):608-17. PubMed ID: 10886301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD.
    Villadsen MM; Bünger MH; Carstens M; Stenkjaer L; Langdahl BL
    Osteoporos Int; 2005 Apr; 16(4):411-6. PubMed ID: 15300362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of transforming growth factor-beta1 (TGFbeta1) T29 --> C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal german women.
    Hinke V; Seck T; Clanget C; Scheidt-Nave C; Ziegler R; Pfeilschifter J
    Calcif Tissue Int; 2001 Dec; 69(6):315-20. PubMed ID: 11800227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women.
    Mondockova V; Adamkovicova M; Lukacova M; Grosskopf B; Babosova R; Galbavy D; Martiniakova M; Omelka R
    BMC Med Genet; 2018 Sep; 19(1):174. PubMed ID: 30241506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women.
    Lau HH; Ho AY; Luk KD; Kung AW
    Calcif Tissue Int; 2004 Jun; 74(6):516-21. PubMed ID: 15354859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women.
    Yamada Y; Miyauchi A; Goto J; Takagi Y; Okuizumi H; Kanematsu M; Hase M; Takai H; Harada A; Ikeda K
    J Bone Miner Res; 1998 Oct; 13(10):1569-76. PubMed ID: 9783545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.
    Langdahl BL; Uitterlinden AG; Ralston SH; Trikalinos TA; Balcells S; Brandi ML; Scollen S; Lips P; Lorenc R; Obermayer-Pietsch B; Reid DM; Armas JB; Arp PP; Bassiti A; Bustamante M; Husted LB; Carey AH; Pérez Cano R; Dobnig H; Dunning AM; Fahrleitner-Pammer A; Falchetti A; Karczmarewicz E; Kruk M; van Leeuwen JP; Masi L; van Meurs JB; Mangion J; McGuigan FE; Mellibovsky L; Mosekilde L; Nogués X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Ioannidis JP; ; ; ; ; ; ; ;
    Bone; 2008 May; 42(5):969-81. PubMed ID: 18284942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Nov; 15(11):2222-30. PubMed ID: 11092403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women.
    Bertoldo F; D'Agruma L; Furlan F; Colapietro F; Lorenzi MT; Maiorano N; Iolascon A; Zelante L; Locascio V; Gasparini P
    J Bone Miner Res; 2000 Apr; 15(4):634-9. PubMed ID: 10780855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of transforming growth factor beta1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis.
    Yamada Y; Harada A; Hosoi T; Miyauchi A; Ikeda K; Ohta H; Shiraki M
    J Bone Miner Res; 2000 Mar; 15(3):415-20. PubMed ID: 10750555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense polymorphisms of the WNT16 gene are associated with bone mass, hip geometry and fractures.
    García-Ibarbia C; Pérez-Núñez MI; Olmos JM; Valero C; Pérez-Aguilar MD; Hernández JL; Zarrabeitia MT; González-Macías J; Riancho JA
    Osteoporos Int; 2013 Sep; 24(9):2449-54. PubMed ID: 23417354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
    Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
    Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T869C TGF beta polymorphism is associated with fracture, bone mineral density, and calcaneal quantitative ultrasound in elderly women.
    Dick IM; Devine A; Li S; Dhaliwal SS; Prince RL
    Bone; 2003 Sep; 33(3):335-41. PubMed ID: 13678774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck bmd in Spanish postmenopausal women.
    Bustamante M; Nogués X; Agueda L; Jurado S; Wesselius A; Cáceres E; Carreras R; Ciria M; Mellibovsky L; Balcells S; Díez-Pérez A; Grinberg D
    Calcif Tissue Int; 2007 Oct; 81(4):327-32. PubMed ID: 17878995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the C-509-->T polymorphism, alone of in combination with the T869-->C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women.
    Yamada Y; Miyauchi A; Takagi Y; Tanaka M; Mizuno M; Harada A
    J Mol Med (Berl); 2001 Apr; 79(2-3):149-56. PubMed ID: 11357939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women.
    Langdahl BL; Knudsen JY; Jensen HK; Gregersen N; Eriksen EF
    Bone; 1997 Mar; 20(3):289-94. PubMed ID: 9071481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of association and linkage disequilibrium between a novel polymorphism in the transforming growth factor beta 1 gene and hip bone mineral density: a study of female twins.
    Keen RW; Snieder H; Molloy H; Daniels J; Chiano M; Gibson F; Fairbairn L; Smith P; MacGregor AJ; Gewert D; Spector TD
    Rheumatology (Oxford); 2001 Jan; 40(1):48-54. PubMed ID: 11157141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk.
    González-Bofill N; Husted LB; Harsløf T; Tofteng CL; Abrahamsen B; Eiken P; Vestergaard P; Langdahl BL
    Osteoporos Int; 2011 Apr; 22(4):1145-56. PubMed ID: 20571774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.